Cargando…

Febrile neutropenia studies in Brazil - treatment and cost management based on analyses of cases

Detalles Bibliográficos
Autor principal:	Bellesso, Marcelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621623/ https://www.ncbi.nlm.nih.gov/pubmed/23580872 http://dx.doi.org/10.5581/1516-8484.20130002

Ejemplares similares

Use of biomarkers in the management of febrile neutropenia episodes in children with cancer()
por: de Oliveira, Benigna Maria
Publicado: (2016)

Stress-induced hyperglycemia is a valuable biomarker in febrile neutropenia
por: Carmona-Bayonas, Alberto, et al.
Publicado: (2013)

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA
por: Catic, Tarik, et al.
Publicado: (2016)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Evaluating the Use of Meropenem in Hematologic Patients with Febrile Neutropenia: A Retrospective Observational Single-Cohort Study
por: Stuurman, R.A., et al.
Publicado: (2023)

Blood group polymorphisms in Brazil()
por: Castilho, Lilian
Publicado: (2016)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Timely Assessment and Management of Febrile Neutropenia
por: Viale, Pamela Hallquist
Publicado: (2019)

The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão()
por: Viana, Marcos Borato
Publicado: (2015)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Tools to implement and improve blood donor hemovigilance in Brazil
por: de Almeida Neto, Cesar
Publicado: (2014)

Ceftolozane-Tazobactam for Febrile Neutropenia Treatment in Hematologic Malignancy Patients Colonized by Multi-Resistant Enterobacteriaceae: Preliminary Results from a Prospective Cohort Study
por: Marchesi, Francesco, et al.
Publicado: (2020)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Risk behavior disclosure among blood donors in Sao Paulo, Brazil
por: Gonçalez, Thelma Therezinha
Publicado: (2012)

Impact of effective prevention and management of febrile neutropenia
por: Krell, D, et al.
Publicado: (2009)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Tool for Guidance: Evidence-Based Recommendations for Managing Febrile Neutropenia
por: Ullmann, Andrew J.
Publicado: (2011)

Comment: seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão Brazil
por: Carvalho, Edgar M.
Publicado: (2014)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Comment on: Blood discard rate and the prevalence of infectious and contagious diseases in blood donors from provincial towns of the state of Paraná, Brazil
por: Venturini, Danielle
Publicado: (2013)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore
por: Wang, Xiao Jun, et al.
Publicado: (2014)

Clozapine-Induced Febrile Neutropenia and Cellulitis
por: YAYLACI, Selcuk, et al.
Publicado: (2016)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021)

Felty’s syndrome – a rare case of febrile neutropenia
por: Rodrigues, Luís, et al.
Publicado: (2021)

Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia
Publicado: (2021)

Anemia in the elderly: an important clinical problem
por: Cliquet, Marcelo Gil
Publicado: (2013)

PB2258: MANAGEMENT OF FEBRILE NEUTROPENIA IN LEUKEMIC PATIENTS: A MONOCENTRIC STUDY
por: Boufrikha, W., et al.
Publicado: (2022)

On the relevance of outpatient intravenous iron therapy for anemia management
por: Muñoz, Manuel
Publicado: (2011)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment
por: Hansen, Bent-Are, et al.
Publicado: (2019)

Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children
por: Morgan, Jessica E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fv53kaemqg26hr359gvtm634e